Flow-dependent dilation mediated by endogenous kinins requires angiotensin AT2 receptors

Circulation Research

Volumn 94, Issue 12, 2004, Pages 1623-1629

  Bergaya, Sonia ^a   Hilgers, Rob H P ^a,b   Meneton, Pierre ^a,c   Dong, You ^a   Bloch Faure, May ^a,c   Inagami, Tadashi ^a,d   Alhenc Gelas, François ^a,c   Lévy, Bernard I ^a   Boulanger, Chantal M ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c INSERM   (France)

^d VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Angiotensin AT 2 receptor; Angiotensin II; Bradykinin B2 receptor; Flow dependent vasodilation; Kinins

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BRADYKININ; BRADYKININ B2 RECEPTOR; BRADYKININ B2 RECEPTOR ANTAGONIST; CANDESARTAN; ICATIBANT; KININ DERIVATIVE; LOSARTAN; NITRIC OXIDE; SARALASIN; TISSUE KALLIKREIN;

ANIMAL TISSUE; ARTERY DIAMETER; ARTERY PERFUSION; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; GENE EXPRESSION; HEART DILATATION; KALLIKREIN KININ SYSTEM; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR UPREGULATION; WILD TYPE;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; ACETYLCHOLINE; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; BENZIMIDAZOLES; BRADYKININ; CAROTID ARTERIES; HEMORHEOLOGY; IMIDAZOLES; LOSARTAN; MALE; MESENTERIC ARTERIES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PHENYLEPHRINE; PYRIDINES; RECEPTOR, ANGIOTENSIN, TYPE 2; RECEPTOR, BRADYKININ B2; TETRAZOLES; TISSUE KALLIKREINS; VASODILATION; VASODILATOR AGENTS;

EID: 3042820768     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.0000131497.73744.1a     Document Type: Article

References (40)

1. Schmaier A, Kuo A, Lundberg D, Murray S, Cines D. The expression of high molecular weight kininogen in human umbilical vein endothelial cells. J Biol Chem. 1988;263:16327-16333.
2. Oza N, Schwartz J, Gould H, Levinsky N. Rat aortic smooth muscle cells in culture express kallikrein-kininogen and bradykinase activity. J Clin Invest. 1990;85:597-600.
3. Nolly H, Lama M, Carretero O, Scicli A. The kallikrein-kinin system in blood vessels. Agents Actions. 1992;38(suppl 3):1-9.
4. Yayama K, Hiroki S, Masaoki T, Hiroshi O. Expression of Low-Molecular-Weight Kininogen in mouse vascular smooth muscle cells. Biol Pharm Bull. 1998;21:772-774.
5. Wiemer G, Scholkens BA, Becker RH, Busse R. Ramiprilat enhances endothelial autacoid formation by inhibiting breakdown of endothelium-derived bradykinin. Hypertension. 1991;18:558-563.
6. Gardes J, Baussant T, Corvol P, Ménard J, Alhenc-Gelas F. Effect of bradykinin and kininogens in isolated rat kidney vasoconstricted by angiotensin II. Am J Physiol. 1990;258:F1273-F1281.
7. Mombouli JV, Vanhoutte PM. Kinins mediate kallikrein-induced endothelium dependent relaxations in isolated canine coronary arteries. Biochem Biophys Res Comm. 1992;185:693-697.
8. Sakakibara T, Hintze TH, Nasjeletti A. Determinants of kinin release in isolated rat hindquarters. Am J Physiol. 1998;43:R120-R125.
9. Mombouli JV, Vanhoutte PM. Kinins and endothelium-dependent relaxations to converting enzyme inhibitors in perfused canine arteries. J Cardiovasc Pharm. 1991;18:926-927.
10. Bergaya S, Meneton P, Bloch-Faure M, Mathieu E, Alhenc-Gelas F, Levy BI, Boulanger CM. Decreased flow-dependent dilation in carotid arteries of tissue-kallikrein-knockout mice. Circ Res. 2001;88:593-599.
11. Pohl U, Holtz J, Busse R, Bassenge E. Crucial role of endothelium in the vasodilator response to increased flow in vivo. Hypertension. 1986;8:37-44.
12. Rubanyi GM, Romero JC, Vanhoutte PM. Flow-induced release of endothelium-derived relaxing factor. Am J Physiol. 1986;250:H1145-H1149.
13. Joannides R, Haefeli WE, Linder L, Richard V, Bakkali EH, Thuillez C, Luscher TF. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation. 1995;91:1314-1319.
14. Davies P. Flow-mediated signal transduction in endothelial cells. In: JA Bevan, G Kaley, GM Rubanyi, eds. Flow-Dependent Regulation of Vascular Function. New York: Oxford University Press; 1995:46-61.
15. Matrougui K, Loufrani L, Heymes C, Levy B. I, Henrion D. Activation of AT2 receptors by endogenous angiotensin II is involved in flow-induced dilatation in rat resistance arteries. Hypertension. 1999;34:659-665.
16. 2-receptors in endothelial cells and isolated ischemic rat hearts. Pharm Pharmacol Lett. 1993;3:24-27.
17. Seyedi N, Xu X, Nasjletti A, Hintze TH. Coronary kinin generation mediates nitric oxide release after angiotensin receptor stimulation. Hypertension. 1995;26:164-170.
18. Liu YH, Yang XP, Sharov VG, Nass O, Sabbah HN, Peterson E, Carretero OA. Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure: role of kinins and angiotensin II type 2 receptors. J Clin Invest. 1997;99:1926-1935.
19. 2 subtype receptor of angiotensin II. From large arteries to the microcirculation. Hypertension. 2001;38:1150-1157.
20. 2 receptor stimulation increases aortic cyclic GMP in SHRSP by a kinin-dependent mechanism. Hypertension. 1998;31:349-355.
21. Siragy HM, Inagami T, Ichiki T, Carey RM. Sustained hypersensitivity to angiotensin II and its mechanism in mice lacking the subtype-2 (AT2) angiotensin receptor. Proc Natl Acad Sci U S A. 1999;96:6506-6510.
22. Tanaka M, Tsuchida S, Imai T, Fuji N, Miyazaki H, Ichiki T, Naruse M, Inagami T. Vascular response to angiotensin II is exaggerated through an upregulation of AT1 receptor in AT2 knockout mice. Biochem Biophys Res Commun. 1999;258:194-198.
23. Katada J, Majima M. AT2 receptor-dependent vasodilation is mediated by activation of vascular kinin generation under flow conditions. Br J Pharmacol. 2002;136:484-491.
24. Vanhoutte PM. Endothelial AT2-receptors: chicken or egg? Br J Pharmacol. 2002;136:481-483.
25. Tsutsumi Y, Matsubara H, Masaki H, Kurihara H, Murasawa S, Takai S, Miyazaki M, Nozawa Y, Ozono R, Nakagawa K, Miwa T, Kawada N, Mori Y, Shibasaki Y, Tanaka Y, Fujiyama S, Koyama Y, Fujiyama A, Takahashi H, Iwasaka T. Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation. J Clin Invest. 1999;104:925-935.
26. Meneton P, Bloch-Faure M, Hagege A, Ruetten H, Huang W, Bergaya S, Ceiler D, Gehring D, Martins I, Salmon G, Boulanger C. M, Nussberger J, Crozatier B, Gasc JM, Heudes D, Bruneval P, Doestchman M, Ménard J, Alhenc-Gelas F. Cardiovascular abnormalities with normal blood pressure in tissue kallikrein-deficient mice. Proc Natl Acad Sci U S A. 2001;98:2634-2639.
27. Ichiki T, Labosky PA, Shiota C, Okuyama S, Imagawa Y, Fogo A, Niimura F, Ichikawa I, Hogan BL, Inagami T. Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor. Nature. 1995;377:748-750.
28. Senbonmatsu T, Ichihara S, Price E, Gaffney F. A and Inagami T. Evidence for angiotensin type 2 receptor-mediated cardiac myocyte enlargement during in vivo pressure overload. J Clin Invest. 2000;106:81-85.
29. Nakajima M, Mukoyama M, Pratt RE, Horiuchi M, Dzau YJ. Cloning of cDNA and analysis of the gene for mouse angiotensin II type 2 receptor. Biochem Biophys Res Commun. 1993;197:393-399.
30. Wallenstein S, Zucker CL, Fleiss JL. Some statistical methods useful in circulation research. Circ Res. 1980;47:1-9.
31. Groves P, Kurz S, Hanjürg J, Drexler H. Role of endogenous bradykinin in human coronary vasomotor control. Circulation. 1995;92:3424-3430.
32. Hutchinson HG, Hein L, Fujinaga M, Pratt RE. Modulation of vascular development and injury by angiotensin II. Cardiovasc Res. 1999;41:689-700.
33. Caputo L, Benessiano J, Boulanger CM, Levy BI. Angiotensin II increases cGMP content via endothelial angiotensin II AT1 subtype receptors in the rat carotid artery. Arterioscler Thromb Vasc Biol. 1995;15:1646-1651.
34. Boulanger CM, Caputo L, Levy BI. Endothelial AT1-mediated release of nitric oxide decreases angiotensin II contractions in rat carotid artery. Hypertension. 1995;26:752-757.
35. 2-) coupling in vascular endothelial cells. Am J Physiol. 1991;261:H149-H156.
36. 2+ signaling of vascular endothelial cells: effects of shear stress and ATP. Am J Physiol. 1991;260:H1698-H1707.
37. Rieder MJ, Carmona R, Krieger JE, Pritchard KA Jr., Greene AS. Suppression of angiotensin-converting enzyme expression and activity by shear stress. Circ Res. 1997;80:312-319.
38. Kramer HJ. The renal kallikrein-kinin system. Renal Physiol. 1979;80:107-121.
39. Rabinovich SE, Lobareva LS, Paskhina TS. Purification and some physico-chemical and enzymatic properties of tissue kallikrein from human urine. Biokhimiia. 1990;55:1675-1689.
40. 1 receptor antagonist. J Biol Chem. 2001;276:39721-39726.